MANDEVILLE THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99278778
- Mark type
- Stylized text
- Filed
- 11 Jul 2025
- Published for opposition
- 30 Dec 2025
- Attorney of record
- DANIEL FRANCIS CHIAFAIR
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of kidney disease; Therapeutic pharmaceutical for the treatment of kidney disease
Owner
- Mandeville Therapeutics, Inc., Woburn, MA, US
- Mandeville Therapeutics, Inc., Woburn, MA, US
Prosecution history
- 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Dec 2025 — PUBLISHED FOR OPPOSITION
- 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2025 — ASSIGNED TO EXAMINER
- 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Jul 2025 — NEW APPLICATION ENTERED
- 11 Jul 2025 — APPLICATION FILING RECEIPT MAILED